InnoCare Optoelectronics (6861) Q1 2025 earnings summary

Executive summary

• Revenue for Q1 2024 was NT$536.8 million, up 17% year-over-year from NT$458.3 million in Q1 2023.

• Net income for Q1 2024 reached NT$42.9 million, doubling from NT$20.4 million in Q1 2023.

• Gross margin improved to 27% from 25% year-over-year.

• Earnings per share (EPS) for Q1 2024 were NT$1.03 (basic), up from NT$0.51 in Q1 2023.

Financial highlights

• Operating income for Q1 2024 was NT$25.7 million, compared to an operating loss of NT$13.6 million in Q1 2023.

• Operating expenses decreased to NT$119.8 million from NT$128.8 million year-over-year.

• Cash and cash equivalents at March 31, 2024, were NT$803.9 million, up from NT$593.5 million a year earlier.

• Total assets grew to NT$2,477.6 million from NT$2,229.0 million year-over-year.

Outlook and guidance

• Management expects continued growth in X-ray flat panel sensor modules, supported by strong demand in medical applications.

• Dividend payout for 2023 is proposed at NT$1.8 per share, pending shareholder approval.